In this case, we report a 73 years-old man with the pathological diagnosis of sarcomatoid urothelial carcinoma of urinary bladder who survived without recurrence for 27 months after bladder sparing treatment and died due to cerebrovascular disease
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Carcinosarcoma or sarcomatoid carcinoma of the urinary bladder has a poor prognosis with a short time from diagnosis to death despite aggressive treatment.
📊
Key Findings & Data:Carcinosarcoma or sarcomatoid carcinoma of the urinary bladder has a poor prognosis with a short time from diagnosis to death despite aggressive treatment.
💡
Conclusion & Impact:In this case, we report a 73 years-old man with the pathological diagnosis of sarcomatoid urothelial carcinoma of urinary bladder who survived without recurrence for 27 months after bladder sparing treatment and died due to cerebrovascular disease
Carcinosarcoma or sarcomatoid carcinoma of the urinary bladder has a poor prognosis with a short time from diagnosis to death despite aggressive treatment. In this case, we report a 73 years-old man with the pathological diagnosis of sarcomatoid urothelial carcinoma of urinary bladder who survived without recurrence for 27 months after bladder sparing treatment and died due to cerebrovascular disease
Özet
Mesanenin karsinosarkom veya sarkomatoid karsinomu kötü prognozlu olup, agresif cerrahi tedaviye rağmen hastalar kısa sürede kaybedilmektedir. Bu makalede patolojisi sarkomatoid ürotelyal karsinom gelen 73 yaşında erkek hastada, mesane koruyucu yaklaşımla yapılan tedavi ve hastalıksız olarak geçen 27 aylık süreç sonrası beyin damar hastalığı nedeniyle ölen olgu sunulmuştur
Gül, Ü., Kuzgunbay, B., Bal, N., Yayacıoğlu, Ö. (2012). Bladder sparing approach in a patient with giant non-muscle invasive sarcomatoid urothelial carcinoma of the bladder. Yeni Üroloji Dergisi, Volume: 7 Issue: 1. https://ajindex.com/articles/1315593
Kayaselcuk F, Bal N, Güvel S, et al. Carcinosarcoma and squa- mous cell carcinoma of the renal pelvis associated with neph- rolithiasis: a case report of each tumor type. Pathol Res Pract 2003;199:489-92.
Maestroni U, Giollo A, Barbieri A, et al. Bladder carcinosarco- ma: a case observation. Acta Biomed 2004;75:74-6.
Lopez-Beltran A, Pacelli A, Rothenberg HJ, et al. Carcinosar- coma and sarcomatoid carcinoma of the bladder: clinicopat- hological study of 41 cases. J Urol 1998;159:1497-503.
Mukhopadhyay S, Shrimpton AE, Jones LA, Nsouli IS, Ab- raham NZ Jr. Carcinosarcoma of the urinary bladder follo- wing cyclophosphamide therapy: evidence for monoclonal
Figure 4. Vimentin positivity in sarcomatoid areas (Vimentin×400) origin and chromosome 9p allelic loss. Arch Pathol Lab Med 2004;128: 8-11.
Ogishima T, Kawachi Y, Saito A, et al. Sarcomatoid carci- noma and carcinosarcoma of the urinary bladder. Int J Urol 2002;9:354-8.
Gronau S, Menz CK, Melzner I, et al. Immunohistomorpholo- gic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder. Virchows Arch 2002;440: 436-40.